 |
|
| Blog results | Results 1 - 10 of about 27,122 for orlistat fda. (0.26 seconds) |
| Sorted by relevance Sort by date |
| 8 Sep 2009 The FDA has announced that it is reviewing safety information regarding orlistat users (available over-the-counter in the U.S. as Alli and by prescription as Xenical) and possible risk of liver damage. According to the FDA: "Between ... About.com Weight Loss - http://weightloss.about.com/b/ - References |
| 18 Dec 2009 by Branded1 BUY ORDER ORLISTAT DISCOUNT ORLISTAT BELGIUM FDA APPROVED PHARMA PRODUCTS BUY COD ORLISTAT DISCOUNT ORLISTAT CANADA FREE TRIAL NO PRESCR'S BUY ORLISTAT DISCOUNT ORLISTAT GERMANY SHIPPED BY CASH ON DELIVERY ONLINE CHEAP ORLISTAT DISCOUNT ... Loving Wii Forums - Wii Game Saves - http://forums.lovingwii.com/ [ More results from Loving Wii Forums - Wii Game Saves ] |
| 26 Aug 2009 by Mark Zamora The FDA said it has received 32 reports of serious liver injury -- including six cases of liver failure -- among users of diet drug orlistat, which is sold as a prescription drug under the trade name Xenical and as an over-the-counter ... A Georgia Lawyer - http://ageorgialawyer.blogspot.com/ |
| 25 Aug 2009 by Dan Schiff FDA's announcement it is investigating a possible risk of liver injury related to orlistat -- the active ingredient in Roche Pharmaceuticals' prescription weight-loss drug Xenical and GlaxoSmithKline's OTC alli –- could threaten future ... OverTheCounterToday - http://www.overthecountertoday.com/ [ More results from OverTheCounterToday ] |
| 22 Sep 2009 by bowersc The FDA is reviewing the safety information for Orlistat following reports of serious liver injury. However, no definite association between liver injury and orlistat has been established at this time. ... NPCi blog - http://www.npci.org.uk/blog/ |
| 28 Aug 2009 by John Cooper The FDA alerted healthcare professionals and patients that its reviewing new safety findings that report liver-related adverse events in patients taking the medication known as orlistat. Orlistat... Northeast NC Personal Injury Lawyer - http://northeast-nc.injuryboard.com/wrongful-death/deadly-c... |
| 25 Aug 2009 The FDA has notified healthcare professionals and consumers that it is reviewing new safety information regarding reports of liver-related adverse events in patients taking orlistat, which is marketed in the US as Xenical (from Roche) ... Latest articles from MPR - http://www.empr.com/ [ More results from Latest articles from MPR ] |
| 31 Aug 2009 by Hugo Ottolenghi For orlistat, the FDA is conducting a review because, “no definite association between liver injury and orlistat has been established at this time,” according to the release. “Consumers taking Xenical should continue to take it as ... The Nutritional and Dietary Supplement Law Blog - http://nutrisuplaw.com/ - References |
| 31 Aug 2009 by Cheryl A. Thompson FDA advised orlistat users to consult their health care professional if they have symptoms possibly associated with the development of liver injury, particularly weakness, fatigue, fever, brown urine, or yellowing of the skin or whites ... ASHP Health-System Pharmacy News - http://www.ashp.org/Import/NEWS/HealthSystemPharmacyNews.aspx |
| 4 Sep 2009 The letter followed up on an FDA news release from August 24 regarding the Agency's ongoing review of liver-related adverse events in patients taking orlistat. FDA stated that patients taking prescription or OTC orlistat should continue ... American Pharmacists Association - http://www.pharmacist.com/ |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
